ATE514716T1 - Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität - Google Patents
Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivitätInfo
- Publication number
- ATE514716T1 ATE514716T1 AT03727860T AT03727860T ATE514716T1 AT E514716 T1 ATE514716 T1 AT E514716T1 AT 03727860 T AT03727860 T AT 03727860T AT 03727860 T AT03727860 T AT 03727860T AT E514716 T1 ATE514716 T1 AT E514716T1
- Authority
- AT
- Austria
- Prior art keywords
- fragments
- antiviral activity
- toxin
- antimicrobial
- microbicidal
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 title abstract 2
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 230000003641 microbiacidal effect Effects 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 150000008574 D-amino acids Chemical class 0.000 abstract 1
- 108010022954 Yeast Killer Factors Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 239000000816 peptidomimetic Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 239000003122 yeast killer factor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210783.7A GB0210783D0 (en) | 2002-05-10 | 2002-05-10 | Anti-microbial polypeptides |
| PCT/IB2003/002348 WO2003095493A2 (en) | 2002-05-10 | 2003-05-09 | Toxin-related antibodies with antimicrobial and antiviral activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE514716T1 true ATE514716T1 (de) | 2011-07-15 |
Family
ID=9936462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03727860T ATE514716T1 (de) | 2002-05-10 | 2003-05-09 | Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7722876B2 (de) |
| EP (1) | EP1504036B1 (de) |
| JP (1) | JP4405912B2 (de) |
| AT (1) | ATE514716T1 (de) |
| AU (1) | AU2003233108A1 (de) |
| BR (1) | BR0309921A (de) |
| CA (1) | CA2484704A1 (de) |
| CO (1) | CO7220324A2 (de) |
| DK (1) | DK1504036T3 (de) |
| GB (1) | GB0210783D0 (de) |
| NZ (1) | NZ536957A (de) |
| WO (1) | WO2003095493A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2006093071A1 (ja) * | 2005-02-28 | 2008-08-07 | 株式会社ジーンケア研究所 | βグルカン合成酵素を有する真菌に対して抗真菌活性を有する抗イディオタイプ抗体、およびその利用 |
| AU2009319864A1 (en) * | 2008-11-25 | 2011-07-14 | Biogen Idec Ma Inc. | Use of DR6 and P75 antagonists to promote survival of cells of the nervous system |
| WO2011060393A1 (en) * | 2009-11-16 | 2011-05-19 | Rasna Therapeutics | Antimicrobial, antiviral, anticancer and immunomodulatory peptides and uses therefore |
| CA2858350A1 (en) | 2011-01-14 | 2013-07-19 | The Regents Of The University Of California | Therapeutic antibodies against ror-1 protein and methods for use of same |
| EP2731677B1 (de) * | 2011-07-11 | 2018-04-18 | Glenmark Pharmaceuticals S.A. | An ox40 bindende antikörper und ihre verwendungen |
| WO2020257625A1 (en) * | 2019-06-21 | 2020-12-24 | Rowley Paul A | Compositions and methods for inhibiting yeast infections |
| US20220111018A1 (en) * | 2020-06-19 | 2022-04-14 | University Of Idaho | Compositions and methods for inhibiting yeast infections |
| CN111848740B (zh) * | 2020-08-04 | 2023-03-24 | 南京市妇幼保健院 | 一种阴道分泌源性多肽及其在抑制白色念珠菌感染中的应用 |
| EP4147716A1 (de) * | 2021-09-10 | 2023-03-15 | Samatva Research Corporation | In einer matrix immobilisierte anti-virus komponente |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| AU669379B2 (en) * | 1992-09-07 | 1996-06-06 | Kyowa Hakko Kirin Co., Ltd. | Humanized antibodies |
| WO1998008090A1 (en) | 1995-06-06 | 1998-02-26 | Epigen, Inc. | Anti-idiotypic antibodies to an epiglycanin |
| JP3946256B2 (ja) * | 1995-09-11 | 2007-07-18 | 協和醗酵工業株式会社 | ヒトインターロイキン５受容体α鎖に対する抗体 |
| HUP9901562A3 (en) * | 1996-05-04 | 2000-06-28 | Astrazeneca Ab | Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| ES2364266T3 (es) * | 1998-04-03 | 2011-08-30 | Chugai Seiyaku Kabushiki Kaisha | Anticuerpo humanizado hacia el factor tisular humano (tf) y procedimiento para construir el anticuerpo humanizado. |
| ES2270638T3 (es) | 1998-10-29 | 2007-04-01 | Dakocytomation Denmark A/S | Deteccion de microorganismos acido-resistentes en las heces. |
| CN1360596A (zh) | 1999-02-12 | 2002-07-24 | 遗传研究所有限公司 | 与b7分子发生反应的人源化免疫球蛋白及应用该免疫球蛋白的治疗方法 |
| DE60040466D1 (de) | 1999-06-17 | 2008-11-20 | Kyowa Hakko Kogyo Kk | Diagnostikum und heilmittel für krankheiten unter teilnahme von makrozyten/makrophagen |
| US7740841B1 (en) * | 2000-01-28 | 2010-06-22 | Sunnybrook Health Science Center | Therapeutic method for reducing angiogenesis |
| EP1130032A1 (de) | 2000-02-28 | 2001-09-05 | Gesellschaft für biotechnologische Forschung mbH (GBF) | Einzelkette-Antikörper die den menschlichen vaskulären endothelialen Wachstumsfaktorrezeptor-2 (VEGFR-2/KDR) erkennen |
| DE10019967A1 (de) | 2000-04-20 | 2001-10-25 | Fenning Biomed Gmbh Dr | Antikörper gegen natives gp96, deren Herstellung und Verwendung |
| BR0112272A (pt) * | 2000-06-22 | 2003-05-06 | Genentech Inc | Anticorpo monoclonal anti-trkc agonista, cadeia pesada de anticorpo anti-trkc, cadeia leve de anticorpo anti-trkc, cadeia pesada de anticorpo anti-trkc murino, cadeia pesada de anticorpo anti-trkc humano, anticorpo agonista anti-trkc murino, anticorpo agonista anti-trkc humano, moléculas de ácido nucléico isolado, moléculas de ácido nucléico, vetor, linhagens de células hospedeiras, linhagens de células de hibridoma, célula hospedeira, polipeptìdeo, composição farmacêutica, método para o tratamento de neuropatia ou doença neurodegenerativa ou reparo de uma célula nervosa lesionada, método para aumentar a proliferação, manutenção ou regeneração de neurÈnios periféricos, método para o tratamento de doença ou condição que envolve a degeneração celular em um paciente mamìfero, método de indução de angiogênese, método de fabricação de um anticorpo anti-trkc, usos de um anticorpo |
-
2002
- 2002-05-10 GB GBGB0210783.7A patent/GB0210783D0/en not_active Ceased
-
2003
- 2003-05-09 DK DK03727860.3T patent/DK1504036T3/da active
- 2003-05-09 EP EP03727860A patent/EP1504036B1/de not_active Expired - Lifetime
- 2003-05-09 US US10/514,781 patent/US7722876B2/en not_active Expired - Fee Related
- 2003-05-09 BR BR0309921-0A patent/BR0309921A/pt not_active Application Discontinuation
- 2003-05-09 AT AT03727860T patent/ATE514716T1/de not_active IP Right Cessation
- 2003-05-09 JP JP2004503507A patent/JP4405912B2/ja not_active Expired - Fee Related
- 2003-05-09 AU AU2003233108A patent/AU2003233108A1/en not_active Abandoned
- 2003-05-09 CA CA002484704A patent/CA2484704A1/en not_active Abandoned
- 2003-05-09 NZ NZ536957A patent/NZ536957A/en unknown
- 2003-05-09 WO PCT/IB2003/002348 patent/WO2003095493A2/en active Application Filing
-
2004
- 2004-12-10 CO CO04124128A patent/CO7220324A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4405912B2 (ja) | 2010-01-27 |
| EP1504036A2 (de) | 2005-02-09 |
| JP2006506959A (ja) | 2006-03-02 |
| CA2484704A1 (en) | 2003-11-20 |
| DK1504036T3 (da) | 2011-10-24 |
| WO2003095493A2 (en) | 2003-11-20 |
| US7722876B2 (en) | 2010-05-25 |
| CO7220324A2 (es) | 2015-03-20 |
| EP1504036B1 (de) | 2011-06-29 |
| GB0210783D0 (en) | 2002-06-19 |
| AU2003233108A1 (en) | 2003-11-11 |
| NZ536957A (en) | 2006-07-28 |
| US20060280750A1 (en) | 2006-12-14 |
| WO2003095493A3 (en) | 2004-06-03 |
| BR0309921A (pt) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE399177T1 (de) | Derivate therapeutischer peptide | |
| DE69838143D1 (de) | Antimikrobielle peptide | |
| EA200100447A1 (ru) | Гибридные белки на основе бета-интерферона и их применение | |
| DE69732250D1 (de) | Zyklische peptide mit breitspektrum antimikrobieller aktivität | |
| WO2002010195A3 (en) | Modified peptides with increased potency | |
| DE69613137D1 (de) | Zyklische peptidanaloga von somatostatin | |
| HK1030613A1 (en) | Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest | |
| ATE514716T1 (de) | Fragmente toxin-bezogener antikörper, mit antimikrobieller und antiviraler aktivität | |
| ES2172044T3 (es) | Supresion de la proliferacion de celulas t usando fragmentos peptidicos de proteina basica de mielina. | |
| GB9606040D0 (en) | Active peptide | |
| BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
| DE68917837D1 (de) | Peptid-Verbindungen. | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| DK1012175T3 (da) | Peptid med affinitet til koagulationsfaktor VIII | |
| ATE245168T1 (de) | Peptide, die anti-zellanhaftungsaktivität aufweisen | |
| ATE414099T1 (de) | Biologisch aktive peptide | |
| EP1557466A4 (de) | Tumorantigenprotein und dessen verwendung | |
| SE9700301D0 (sv) | New compound | |
| DE59109235D1 (de) | Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung | |
| SG170757A1 (en) | Polypeptide having esterase activity and recombinant esterase and use thereof | |
| AU4956901A (en) | Novel human 7tm proteins and polynucleotides encoding the same | |
| WO1999060117A3 (fr) | Polypeptide prax-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |